The amine-carboxyboranes anti-inflammatory agents were shown to block TNF release at 90 min. and IL-I release at 5 hr. from macrophages. 
Introduction
Amine-carboxyboranes and related derivatives have been shown to be potent anti-inflammatory and antioosteoporosis agents in rodents I'4.
These agents were shown to block septic shock, pleurisy, arthritis and induced edema in mice at doses from 2 to Table 7 ]. At 12.5 BM the maximum reduction of IL-I high affinity binding was Vol. 2, No. 5, 1995 The Relationship Between Cytokine Regulation and Anti-Inflammatory Action of Amine-Carboxyborane [ Tables 8 and 9 ]. (Table 18) . At all times, the calcium uptake was decreased significantly and at 5 hours the uptake of calcium by L929 cells to reach its lowest level for each compound. [Table 20 ]. TNF at I0 or I00 ng/ml of medium did not affect the incorporation of proline into collagen of L929 cells; however, proline incorporation into non-collagen was reduced 24% at i0 ng but not at I00 ng/ml at 90 min.
incubation. (Table 21) .
Compound #I caused a 31-33% reduction of incorporation of proline at all concentrations of drug and was the most effective agent.
Compound #3 caused a 22-28% reduction at all concentrations and Compound #2 was not as effective producing a 14% reduction at 50 M. 5, 6 . This is a chain reaction over time; thus, it is important that an effective anti-inflammatory drug block sequel events in the reaction as well as stimulate the repair process.
The amine-carboxyboranes appear to achieve these goals and further investigation as potential therapeutic agents is warranted.
